About Mitogen

Who we are

Mitogen International Inc specializes in identification of novel autoantibodies and biomarkers for autoimmune diseases.

Mitogen develops new diagnostic technology with application for detection of autoantibodies and autoantigens in biological fluids. Our expertise is in autoantigens of the Golgi complex, endosome and a novel cellular compartment, GW Bodies. We specialize in purification and characterization of intracellular antigens that react with sera of patients with systemic rheumatic and other autoimmune disease.

Mitogen focuses on autoantibodies in patients with idiopathic ataxia and chronic inflammatory demyelinating neuropathy. We follow clinical features of patients with anti-Golgi anti-endosome, anti-GW182 antibodies and anti-DFS-70 antibodies.

Mitogen keeps in mind the role of environmental xenobiotics in the induction and perpetuation of autoimmunity.

Marvin J Fritzler PhD MD

Technologists

Support Staff

Collaborators

Dr. Edward Chan, University of Florida
www.dental.ufl.edu/Faculty/EChan/

Dr. Michael Mahler
mmahler@inovadx.com

Canadian Scleroderma Research Group
Dr. M. Baron, McGill University, Montreal

www.canadian-scleroderma-research-group.ca

Dr.M.Hudson, McGill University, Montreal

Industry Partners

Immuno Concepts, Sacramento, CA
www.immunoconcepts.com

INOVA Diagnostics, San Diego, CA
www.inovadx.com

Euroimmun, Lubeck, Germany
www.euroimmun.de

Eve Technologies Corporation, Calgary, AB
www.evetechnologies.com

Inter Medico Canada,

www.inter-medico.com 

We are members of:

The Cumming School of Medicine

The Department of Medicine

Department of Biochemistry and Molecular Biology

Division of Rheumatology

McCaig Institute for Bone & Joint Health

www.mccaiginstitute.com

Snyder Institute for Chronic Diseases (www.Snyder.ucalgary.ca<http://www.Snyder.ucalgary.ca>)

UC-vert-rgbUC-medicine-cmyk